For the sixth consecutive year, we’ve made the S&P Global Dow Jones Sustainability World Index and for the fifth year, the Dow Jones Sustainability North America Index. The DJSI World Index is a leading benchmark for corporate responsibility, recognizing the top 10 percent of the world’s most sustainable companies in each industry. Guided by our commitment to "Do Well by Doing Good,” we are positioned to meet or exceed our 2025 global responsibility goals. As we look to define future targets, we are working to set new standards for responsible innovation and growth in support of our mission of bringing important new medicines to people with serious diseases. Read more: https://bit.ly/3DvzmeE
Info
At Regeneron we believe that when the right idea finds the right team, powerful change is possible. As we work across our expanding global network to invent, develop and commercialize life-transforming medicines for people with serious diseases, we’re establishing new ways to think about science, manufacturing and commercialization. And new ways to think about health. Connect with us so we can learn more about you, and you can learn more about our biopharmaceutical medicines. And join us, as we build a future we believe in. Please visit www.regeneron.com/social-media-terms for information on how to engage with us on social media. An important note about privacy: Regeneron is committed to your privacy and will not ask for sensitive personal information such as social security number, date of birth or bank account details via email or social media.
- Website
-
http://www.regeneron.com
Externer Link zu Regeneron
- Branche
- Biotechnologie
- Größe
- 10.001+ Beschäftigte
- Hauptsitz
- Tarrytown, New York
- Art
- Kapitalgesellschaft (AG, GmbH, UG etc.)
Orte
Beschäftigte von Regeneron
-
Ed Cowden
Director at Regeneron Pharmaceuticals, Inc.
-
Teresa Guerriero
IT Asset Management Manager at Regeneron Pharmaceuticals, Inc.
-
Juan Rodriguez-Flores, Ph.D.
Computational Genetics and Genomic Medicine
-
Beverly Chamberlain
Global Head of IT Enterprise Services | Information Technology | Strategic Planning | Leadership | Process Improvement | P&L | SDLC
Updates
-
We’re sending our gratitude and best wishes to Neil Stahl, PhD, EVP, Research & Development, who is retiring from Regeneron after 33 years. Neil is a venerated scientist who has contributed to Regeneron’s growth and success in countless ways while helping to shape our special culture. As one colleague remarked, “He is a brilliant mind and an even better human.”
-
When Jennifer Davidson Hamilton started her career, she did not envision that she would one day lead an entire function. With more than a 20-year career at Regeneron, Jennifer knows what it takes to help her team succeed. Read her full article to discover how she uses her journey to implement effective leadership strategies.
-
For some, legacy is defined by the memorable moments you leave behind. To us, legacies aren’t just meant to be left, they’re meant to be lived. Our legacy is translating science to medicine for serious diseases. And our clinical trials are at the heart of this. Through clinical trials, we can answer more questions, develop more potentially life-changing medicines, and discover more possibilities with the goal of offering more hope to patients. Learn about our clinical trials and how you can be part of the scientific discovery: https://bit.ly/4fAlVs4 #WhatsYourLegacy
-
At the Regeneron Genetics Center (RGC), we’re committed to unlocking the potential of human genetics to drive the discovery of new medicines. We gathered at the American Society of Human Genetics with leading geneticists around the world to exchange ideas and showcase impactful new analytic approaches, genetic findings and large-scale sequencing efforts. From advancing discovery to exploring potential clinical applications, we strive to push the boundaries of genomic research. Learn more: https://bit.ly/48SN8DW #ASHG24
-
Investing in #STEM today shapes the future of innovation tomorrow. 🌟🔬 Swipe to learn more about why we're committed to elevating young scientific leaders, and read more about how we're building a thriving STEM ecosystem: https://bit.ly/4hKvh6a
-
We're proud to be ranked #3 in BioSpace's 2025 Best Places to Work in Biopharma! This recognition reflects our innovative culture and commitment to career growth at our company. Thank you to our incredible team for making Regeneron a great place to work! Learn more: bit.ly/4hOvvJF
-
Today on #VeteransDay, Lead Warehouse Associate David Steward shares his incredible journey from the U.S. Army to the world of science. The skills he honed during his service — discipline, leadership and commitment to a cause greater than himself — have shaped his success in his everyday work, his leadership role within our veterans employee resource group, and beyond. Hear more about David’s service-oriented mindset and the unique perspective he brings to Regeneron. https://bit.ly/40ymzBU
-
While every scientific endeavor — from homemade volcanoes to a fascination with the stars in the night sky — begins with a spark of curiosity, students navigating the path to a STEM career can face certain barriers. Christina Chan, Senior Vice President of Corporate Affairs at Regeneron, shares how we’re providing support at critical junctures and helping students tackle these hurdles in their STEM education journeys. Read about how we are uplifting the innovators of tomorrow: https://bit.ly/4hHGnbU #NationalSTEMDay #STEM
-
More than one in four adults in the U.S. have some type of disability.* At Regeneron, we believe an inclusive workplace leads to the best ideas and we celebrate the value that colleagues with disabilities add to our culture. In recognition of National Disability Employment Awareness Month, our ASPIRE Employee Resource Group — which supports colleagues with disabilities and colleagues who are caregivers to people with disabilities — shares their advice on how we can be proactive allies. Read their recommendations on working together to foster a more inclusive workplace through language, actions and a willingness to learn. #NDEAM #DisabilityEmployment #DisabilityInclusion *Source: CDC Disability Impacts All of Us Infographic
Verbundene Seiten
Ähnliche Seiten
Jobs durchsuchen
Aktien
REGN
NASDAQ
Verzögerung von 20 Minuten
701,85 $
-6,4 (-0,904 %)
- Aktiv
- 710,2
- Niedrig
- 700,83
- Hoch
- 717,61
Daten von Refinitiv
Mehr Informationen aufFinanzierung
Letzte Runde
Kapitalerhöhung nach Börsengang2.031.980,00 $